The Pentagon is reinstituting a mandatory program to test US service members for testosterone deficiency, a spokesperson said on Thursday. The policy applies to male service members aged 30 and older and sets uniform screening and treatment pathways.

Several outlets report that this is a return to an earlier approach after the program was paused. They also note that the Pentagon frames the change as supporting readiness. Medical experts cited across the coverage argue that the testing is unnecessary for the population being targeted and may carry potential risks, including possible harm from follow-up steps such as diagnosis and treatment.

While the outlets differ mainly in emphasis—some foreground the “revival” or “resumption” aspect, and others stress the medical concerns—each describes the same core policy: mandatory testosterone deficiency testing for men over 30 and renewed debate over whether the practice is medically justified versus potentially harmful.